This inventor holds 4 USPTO granted patents. Top assignees: Cancer Research Technology Limited, Pharminxo Limited. Active years: 2005-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2008
Title: The Innovative Contributions of Andrew David Westwell
Introduction
Andrew David Westwell is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 4 patents to his name, Westwell's work focuses on innovative chemical structures that have the potential to address serious health conditions.
Latest Patents
Westwell's latest patents include the development of 2-arylbenzothiazole derivatives. This compound is characterized by a general structure that may exist in various forms, including N-oxide or S-oxide. Another significant invention pertains to 4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and their analogs. These compounds are recognized for their potential as antiproliferative agents and anticancer agents, as well as inhibitors of thioredoxin/thioredoxin reductase. The pharmaceutical compositions derived from these compounds are intended for use in treating proliferative conditions, such as cancer.
Career Highlights
Throughout his career, Westwell has worked with prominent organizations, including Cancer Research Technology Limited and Pharminxo Limited. His experience in these companies has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Westwell has collaborated with several professionals in his field, including Tracey Dawn Poole and Geoffrey Wells. These partnerships have facilitated the advancement of his research and the successful development of his patented compounds.
Conclusion
Andrew David Westwell's innovative work in the pharmaceutical sector highlights his commitment to developing effective therapeutic agents. His contributions continue to pave the way for advancements in cancer treatment and other medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile